论文信息 - A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody - 字舞流文

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

D. Berry | J. Cummings | L. Lannfelt | R. Lai | A. Koyama | Scott Berry | J. Kaplow | Jinping Wang | C. Swanson | S. Dhadda | Heather Bradley | L. Reyderman | Yong Zhang | R. Gordon | Lynn D. Kramer | Martin P. Rabe | L. Kramer | Robert Y.K. Lai